Bio-Rad Q3 EBIT margin -7.6%
BIO•Bio-Rad reported a Q3 EBIT margin of -7.6%, net income of $458.6 million, EPS of $17.02, sales of $656.4 million and gross margin of 50.1%.
1. Q3 results
Bio-Rad reported Q3 net income of $458.6 million and EPS of $17.02. Sales were $656.4 million, gross margin was 50.1% and EBIT margin was -7.6%.
